Ameriprise Portfolio holdings
Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nike
NKE
|
+$499M |
| 2 |
Booking.com
BKNG
|
+$328M |
| 3 |
3M
MMM
|
+$285M |
| 4 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$283M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$275M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$552M |
| 2 |
iShares US Healthcare ETF
IYH
|
+$393M |
| 3 |
TJX Companies
TJX
|
+$389M |
| 4 |
iShares US Industrials ETF
IYJ
|
+$387M |
| 5 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$384M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.14% |
| 2 | Financials | 13.78% |
| 3 | Healthcare | 13.65% |
| 4 | Industrials | 9.87% |
| 5 | Consumer Discretionary | 9.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Apple
AAPL
$4.89T
| $3.65B | 2.13% |
132,156,076
+1,413,104
| +1% | +$38.4M |
|
2
Microsoft
MSFT
$2.84T
| $2.47B | 1.44% |
53,188,158
+1,230,289
| +2% | +$57.7M |
|
3
JPMorgan Chase
JPM
$939B
| $2.37B | 1.38% |
37,806,952
+2,526,324
| +7% | +$152M |
|
4
Comcast
CMCSA
$79.1B
| $1.89B | 1.1% |
65,151,150
+7,567,452
| +13% | +$207M |
|
5
Alphabet (Google) Class C
GOOG
$3.9T
| $1.84B | 1.07% |
69,956,259
-4,791,459
| -6% | -$129M |
|
6
Johnson & Johnson
JNJ
$635B
| $1.57B | 0.91% |
14,968,065
-1,055,883
| -7% | -$111M |
|
7
Pfizer
PFE
$140B
| $1.56B | 0.91% |
52,916,693
-6,081,971
| -10% | -$174M |
|
8
Chevron
CVX
$388B
| $1.53B | 0.89% |
13,662,533
-377,934
| -3% | -$42.9M |
|
9
Procter & Gamble
PG
$343B
| $1.51B | 0.88% |
16,603,687
+244,824
| +1% | +$21.5M |
|
10
Visa
V
$677B
| $1.49B | 0.87% |
22,803,804
-603,708
| -3% | -$36.3M |
|
11
Wells Fargo
WFC
$261B
| $1.43B | 0.84% |
26,148,944
+168,372
| +0.6% | +$8.91M |
|
12
Cisco
CSCO
$450B
| $1.41B | 0.82% |
50,859,791
-415,603
| -0.8% | -$10.7M |
|
13
Merck
MRK
$324B
| $1.39B | 0.81% |
25,720,859
+523,779
| +2% | +$29.2M |
|
14
Citigroup
C
$222B
| $1.37B | 0.8% |
25,334,282
+432,797
| +2% | +$23M |
|
|
CELG
15
DELISTED
Celgene Corp
CELG
| $1.34B | 0.78% |
12,003,962
-793,846
| -6% | -$83.7M |
|
16
CVS Health
CVS
$137B
| $1.31B | 0.76% |
13,568,732
+321,851
| +2% | +$28.4M |
|
17
Verizon
VZ
$194B
| $1.29B | 0.75% |
27,589,919
-7,021,122
| -20% | -$344M |
|
|
18
Booking.com
BKNG
$138B
| $1.28B | 0.75% |
28,155,150
+7,257,550
| +35% | +$328M |
|
19
Meta Platforms (Facebook)
META
$1.51T
| $1.23B | 0.72% |
15,728,186
-1,159,527
| -7% | -$88.6M |
|
20
Honeywell
HON
$77.1B
| $1.15B | 0.67% |
12,797,436
+766,148
| +6% | +$65.9M |
|
21
Bristol-Myers Squibb
BMY
$127B
| $1.12B | 0.66% |
19,051,727
-745,703
| -4% | -$42.1M |
|
22
Vertex Pharmaceuticals
VRTX
$121B
| $1.11B | 0.64% |
9,313,819
-184,044
| -2% | -$20.7M |
|
23
Altria Group
MO
$122B
| $1.08B | 0.63% |
21,828,643
+928,210
| +4% | +$45.2M |
|
24
ConocoPhillips
COP
$147B
| $1.06B | 0.62% |
15,401,054
-543,678
| -3% | -$37.9M |
|
25
Philip Morris
PM
$301B
| $1.02B | 0.59% |
12,503,284
-1,390,434
| -10% | -$119M |
|
Similar funds
Ameriprise's Q4 2014 Portfolio in Review
As of Q4 2014, Ameriprise held 6,323 positions worth $172B, up 3.2% from $166B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Ameriprise's Q4 2014 filing shows 103 new, 2,025 increased, 1,377 reduced and 2,563 closed positions. Its largest new stake was Travelport Worldwide Limited: 2,206,982 shares worth $39.7M. The largest sale was Gilead Sciences, an estimated $552M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.
- Ameriprise's largest Q4 2014 buy was Travelport Worldwide Limited: 2,206,982 shares worth $39.7M.
- Ameriprise added most to Nike in Q4 2014, an estimated $499M increase.
- Ameriprise's biggest Q4 2014 reduction was Gilead Sciences, cutting an estimated $552M.
- Ameriprise fully exited CONCUR TECHNOLOGIES INC in Q4 2014, selling an estimated $50.5M.
- Ameriprise's ten largest holdings make up 12% of its $172B portfolio in Q4 2014.
- Ameriprise opened 103 new positions and closed 2,563 in Q4 2014.
- Ameriprise's portfolio value rose 3.2% quarter-over-quarter to $172B.
Based on Ameriprise's 13F filing for Q4 2014, filed 13 Feb 2015.